Source Natural Foods and Herbal Supplements Ltd.

95.13 +0.24 ▲0.3%

23 February 2024, 04:01:00 PM
Volume: 1,424

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.source_natural.com
Market Cap 61.39 Cr.
Enterprise Value(EV) 61.40 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 3.92 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 24.33 Trailing Twelve Months Ending 2023-12
Industry PE 41.88 Trailing Twelve Months Ending 2023-12
Book Value / Share 29.72 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.21 Calculated using Price: 95.37
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.64 Cr. 6,436,931 Shares
FaceValue 10
About Source Natural Foods and Herbal Supplements Ltd.
Inwinex Pharmaceuticals, incorporated in 1995, is engaged in the manufacture of pharmaceuticals. Earlier known as Inwinex Laboratories, it got its present name on March 2, 2007.

Source Natural Foods and Herbal Supplements Ltd. Delivery

Delivered Qty
Traded Qty

Source Natural Foods and Herbal Supplements Ltd. Performance

1 Day
+0.25%
1 Week
-2.21%
1 Month
+0.08%
3 Month
+4.78%
6 Month
+2.46%
1 Year
-23.90%
2 Year
+6.41%
5 Year
+128.68%
10 Year
+1124.32%

Source Natural Foods and Herbal Supplements Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 3.86 8.31 22.42 10.87 12.4 17.65 29.4 16.92 12.73
Return on Capital Employed (%) 3.22 8.94 20.4 11.67 13.56 20.89 33.08 26.4 18.71
Return on Assets (%) 2.75 6.76 15.73 7.31 9.84 14.6 24.11 14.11 10.54

Source Natural Foods and Herbal Supplements Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 5 6 7 8 9 10 13 16 18 18
Non Curr. Liab. 0 0 0 0 0 0 -1 0 0 0
Curr. Liab. 1 1 4 3 2 3 4 3 3 4
Minority Int.
Equity & Liab. 6 7 11 11 10 12 16 19 21 23
Non Curr. Assets 4 3 4 4 4 4 5 5 5 6
Curr. Assets 2 3 8 7 6 9 11 14 17 17
Misc. Exp. not W/O
Total Assets 6 7 11 11 10 12 16 19 21 23

Source Natural Foods and Herbal Supplements Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 7 11 16 11 13 14 25 22 20 27
Other Income 0 0 0 0 0 0 0 0
Total Income 7 11 16 11 13 14 25 22 20 27
Total Expenditure -6 -10 -14 -9 -11 -11 -21 -18 -16 -23
PBIDT 1 1 2 1 2 2 5 4 4 5
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 0 0 0 0 0 0 0 0 -1
Taxation 0 0 0 0 0 -1 -1 -1 -1
Exceptional Items 0
PAT 0 0 1 1 1 2 3 2 2 3
Adjusted EPS 0 1 2 1 2 3 5 4 3 4

Source Natural Foods and Herbal Supplements Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 -1 0 3 0 4 -1 3
Cash Fr. Inv. -1 0 0 -2 0 0 -1 -2 0 0
Cash Fr. Finan. 0 0 0 2 0 -2 0 0 -1 -1
Net Change 0 0 0 -1 0 1 -1 3 -2 2
Cash & Cash Eqvt 0 1 1 0 0 1 0 3 1 3

Source Natural Foods and Herbal Supplements Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 74.37 74.37 74.37 74.37 74.37 74.37 74.37 74.37 74.37
Public 25.63 25.63 25.63 25.63 25.63 25.63 25.63 25.63 25.63
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Source Natural Foods and Herbal Supplements Ltd. Announcements

Thu, 15 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dear Sir/Mam Pursuant to Reg 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith a copy of the newspaper publication "Extract of Standalone Un-audited Financial Results for the quarter and nine months ended on 31st December 2023 published in Financial Express (English) and Sanjevani (Kannada) newspaper on 15th February 2024.
Wed, 14 Feb 2024
Un-Audited Results For The Quarter And Nine Months Ended On 31.12.2023
The Un-audited Financial Results for the quarter and nine months ended on 31st December 2023 as reviewed by the Audit Committee were approved by the Board and it took on records the Limited Review Report in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and IND-AS promulgated.
Wed, 14 Feb 2024
Board Meeting Outcome for Board Meeting Outcome For Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December 2023
With respect to above we wish to inform that the Meeting of Board of Directors of the Company was held on Wednesday the 14th February 2024 wherein the following matters have been discussed and approved:1. The Board noted and took on records the minutes of the meeting of the Audit Committee and Independent Directors Meetings held on the day.2. The Un-audited Financial Results for the quarter and nine months ended 31st December 2023 as reviewed by the Audit Committee were approved by the Board and it also took on record the Limited Review Report in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and IND-AS promulgated.3. The Board took note of the Internal Audit Report issued by M/s Ganga Prakash Chartered Accountants for the quarter and nine months ended 31st December 2023.

Source Natural Foods and Herbal Supplements Ltd. Technical Scans

Fri, 23 Feb 2024
High Delivery Percentage High Delivery Percentage
High Increase in 5 Years High Increase in 5 Years
Closing Near 50 SMA Closing Near 50 SMA
William %R Trending Up William %R Trending Up
Thu, 22 Feb 2024
High Delivery Percentage High Delivery Percentage

Source Natural Foods and Herbal Supplements Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Source Natural Foods and Herbal Supplements Ltd. FAQ's

What is Source Natural Foods share price?

Can I buy Source Natural Foods shares now?

What is the Market Cap of Source Natural Foods?

What are the key metrics to analyse Source Natural Foods?

What is the 52 Week High and Low of Source Natural Foods?

What is the trend of Source Natural Foods share price?